Kalaris Therapeutics OverviewKalaris Therapeutics Other Income Expense Net
Other Income/Expense Net for KLRS.
Quarterly Other Income/Expense
$977000.00
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$3.53M
↓ 24.41% YoY
Trailing 12 months ending Mar 31, 2026